
Is EW (Edwards Lifesciences Corporation) Halal or Haram?
Edwards Lifesciences clears all AAOIFI Shariah screening criteria with exceptional compliance metrics. The company carries negligible debt, representing just 1.5% of its market capitalization, which is well below the 33% threshold. Additionally, its interest income accounts for only 2.45% of total revenue, keeping it safely under the 5% limit.
Price Chart (5D)
EW — Last 7 Days
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| 2026-05-01 | 84.01 | 85.06 | 82.53 | 84.01 | 6.6M | +0.00% |
| 2026-04-30 | 81.53 | 83.63 | 80.65 | 83.50 | 6.6M | +2.42% |
| 2026-04-29 | 81.95 | 82.28 | 80.76 | 81.22 | 5.0M | -0.89% |
| 2026-04-28 | 84.13 | 84.95 | 81.51 | 82.28 | 5.8M | -2.20% |
| 2026-04-27 | 83.54 | 84.79 | 83.22 | 83.46 | 7.2M | -0.10% |
| 2026-04-24 | 82.50 | 84.74 | 82.12 | 84.15 | 11.8M | +2.00% |
| 2026-04-23 | 81.53 | 82.00 | 79.19 | 79.72 | 6.2M | -2.22% |
Discussion
Sign in to join the discussion
Loading comments...
Shariah Screening Details for EW
Business Activity
Permissible
Edwards Lifesciences passes the business activity screen because its core operations—developing transcatheter heart valve replacement and surgical structural heart solutions—provide permissible, life-saving medical devices.
Debt / Market Cap
1.49%
Interest Income
2.45%
Cash & Securities
8.95%
About Edwards Lifesciences Corporation (EW)
Edwards Lifesciences Corporation is a global leader in medical innovations for structural heart disease and critical care monitoring. The company specializes in life-saving devices, notably its transcatheter heart valve replacement systems and the PASCAL transcatheter valve repair therapies used to treat mitral and tricuspid valve diseases.
For Muslim investors, EW currently presents an attractive Halal investment opportunity, having successfully passed all AAOIFI screening criteria. The company's operations in the medical device sector are universally considered permissible, and it comfortably passes all three financial ratio tests required for Shariah compliance.
From an Islamic finance perspective, Edwards Lifesciences boasts an incredibly clean balance sheet with a remarkably low debt-to-market cap ratio of just 1.5%. Furthermore, its cash and interest-bearing securities sit at a safe 8.9% of its market value, ensuring that its primary revenue is driven by core medical sales rather than impermissible financial engineering.
While the company exhibits strong Shariah compliance, investors should continue to monitor its interest income, which currently stands at 2.45% of total revenue. Any significant increase in cash reserves generating interest could push this figure closer to the 5% AAOIFI limit, requiring careful ongoing observation.
CEO
Bernard J. Zovighian
Employees
15,800
IPO Date
2000-03-27
Headquarters
Irvine, CA, US
Website
www.edwards.comEW Key Financial Statistics
Revenue
$6.07B
Net Income
$1.07B
EPS (Diluted)
$1.83
Stock Price
81.92
Beta
0.94
52-Week Range
72.3-87.89
Total Debt
$705.4M
Total Equity
$10.34B
Current Ratio
3.72
EW Financial Health & Profitability
Profit Margins
Revenue Growth (YoY)
+11.5%
Prior year: $5.44B
Net Cash
$2.23B
Cash: $2.94B — Debt: $705.4M
R&D Spending
$1.08B
% of Revenue
17.8%
Frequently Asked Questions About EW
Is EW (Edwards Lifesciences Corporation) stock halal to invest in?▾
What does Edwards Lifesciences Corporation do?▾
What screening criteria were used for EW?▾
Does EW require income purification?▾
When was EW last screened?▾
Disclaimer
This shariah compliance assessment for EW (Edwards Lifesciences Corporation) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.